Xarelto® is an anticoagulant, blood thinning, medication prescribed after surgery to lessen the risk of a patient’s blood clotting deep vein thrombosis (DVT), and pulmonary embolism (PE). Xarelto® was introduced in 2011, and in addition to hip/knee replacement patients, it has been prescribed to individuals with atrial fibrillation (A-fib).
Xarelto® was approved by the FDA in 2011, is manufactured by Bayer, and marketed in the U.S. by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals.
A growing allegation is that Xarelto® is responsible for internal bleeding in a growing number of people using the drug as prescribed. It is also alleged that once the internal bleeding starts there is no antidote or course of action to reverse or stop the bleeding, often times resulting in the death of the user.
In 2014, a lawsuit was filed against the manufacturer of Xarelto® on behalf of a Kentucky woman who allegedly suffered injuries from severe gastrointestinal bleeding that developed after she had used Xarelto®.
The lawsuit claims that there was insufficient labeling, failure to warn the consumer, and multiple counts of negligence on the manufacturer’s part.
The lawsuit also aims to protect and educate individuals and physicians of the possible side effects from using Xarelto®, based on the manufacturer’s failure to make this information accessible prior to introducing drug to the market.
The side effects of using Xarelto® vary widely from person to person, and can be made worse with extended use of the drug, or if there are pre-existing conditions. Some of the known side effects include:
Franklin D. Azar & Associates is currently offering a free consultation to anyone who has suffered from the side effects listed above after taking Xarelto®. If you qualify for the lawsuit, you could be entitled to compensation due to any of the following:
If you or a loved one has suffered, or passed away, due to the use of Xarelto®, please contact our office today. Call 1-800-716-9032, or fill out our contact form on our website.